Clozapine in Reducing Aggression and Violence in Forensic Populations
Popular media often portray people with a mental illness as being aggressive, violent, and incarcerated as a result of their behavior. Despite exaggeration in the media, risks for some aggressive behaviors are in fact higher in individuals with schizophrenia. This is often the case with influence of comorbid substance use disorders. It is essential that mental health professionals are aware of treatments that may help with attenuating and treating behaviors that contribute to violence, aggression and incarceration. This paper reviews violence and incarceration in individuals with schizophrenia as well as recommendations, guidelines and benefits for the use of clozapine in this population. Clozapine remains one of the most underutilized evidence-based medications available in the psychiatric arena in the United States. It is a viable and recommended option in the forensic population and it may be helpful on the path to recovery as well as bring substantial savings to the criminal justice system.
KeywordsClozapine Forensic Violence Aggression Criminal justice
This work was supported in part by grants NIMH R01 MH102215 (Kelly PI) and R01 MH105571-01 (Kelly PI).
Compliance with Ethical Standards
This work was supported in part by grants NIMH R01 MH102215 (Kelly PI) and R01 MH105571–01 (Kelly PI).
Disclosure of Potential Conflicts of Interest
Dr. Raymond Love owns stock in GlaxoSmithKline. All other authors declare that they have no conflict of interest.
Research Involving Human Participants and/or Animals
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
This article does not contain any studies with human participants or animals performed by any of the authors.
- 11.Miami-Dade County Criminal Mental Health Project. [cited 2016 9/7]; Available from: http://www.jud11.flcourts.org/Criminal-Mental-Health-Project.
- 12.Weinstein, H, Kim, D, Mack, A, et al. Prevalence and assessment of mental disorders in correctional settings. Handbook of correctional mental health 2005;43–68.Google Scholar
- 13.James, D and Glaze, L. Mental health problems of prison and jail inmates (Bureau of Justice Statistics Special Report, NCJ 213600). Washington, DC: Department of Justice 2006;Google Scholar
- 25.Love, RC, Kelly, DL, Freudenreich, O, et al. Clozapine underutilization: Addressing the barriers. National Association of State Mental Health Porgram Directors 2016 [cited 2016 October 4]; Available from: http://www.nasmhpd.org/sites/default/files/Assessment%201_Clozapine%20Underutilization.pdf.
- 53.Kelly, DL, Ben-Yoav, H, Payne, GF, et al. Blood Draw Barriers for Treatment with Clozapine and Development of Point-of-Care Monitoring Device. Clin Schizophr Relat Psychoses 2015;Google Scholar
- 56.NC Division of Mental Health, Developmental Disabilities and Substance Abuse Services and the North Carolina Psychiatric Association. Clozapine (Clozaril): an underutilized evidence based treatment [PowerPoint Slides] (n.d.). Retrieved from http://naminc.org/nn/0910Conf/clozapineresearch.pdf.